clinical trial · NCT06772792
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)
Merck Sharp & Dohme LLC·phase1·completed·n = 36
HealthyAlendronateEnlicitide Decanoate
brief summary
The goal of this study is to learn what happens to a single dose of alendronate over time in a healthy participant's body when the participant is given a single dose of enlicitide decanoate. Researchers want to learn how safe and tolerable is the co-administration of enlicitide decanoate and alendronate.
started
Apr 23, 2024
primary completion
Jun 21, 2024
completion
Jun 21, 2024
last updated
Feb 18, 2025
official title
A Clinical Study to Evaluate the Effect of MK-0616 on the Pharmacokinetics of Alendronate in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol